Home › US companies › Avantor

Avantor

AVTR · NYSE · Laboratory Analytical Instruments
Insider buys (12 months)
$7.6M
Insider sales (12 months)
0
8-K reports (12 months)
16
Tracked investors holding
1

At a glance

Avantor reported 2025 revenue of $6.55B, down 3.4% from $6.78B in 2024. Over 4 years since 2021 ($7.39B), that is a decline of about 3% a year. Operating margin was -3.8%, down from 13.2% in 2021. Revenue peaked in 2022 at $7.51B. The company posted a loss in 2025.

In the last 12 months 5 insiders reported 7 open-market purchases ($7.6M) and 0 sales. The largest was a purchase of $3.9M by Director Sanjeev K Mehra on Dec 9, 2025.

Avantor filed 16 current reports (Form 8-K) in the last 12 months, most often for officer or director change (10), results of operations (4), material agreement (1) and new financial obligation (1). The latest officer or director change was reported on Sep 21, 2026. It reported a material agreement or a completed acquisition or disposal 1 time.

1 of the 20 investors tracked here held Avantor at the last quarter end, worth $3M combined. It is the largest weight for Bridgewater Associates (0% of its portfolio). Added: Bridgewater Associates.

Annual results

2021
Revenue $7.39B
Op. $972.2M
2022
Revenue $7.51B
Op. $1.13B
2023
Revenue $6.97B
Op. $696.4M
2024
Revenue $6.78B
Op. $1.08B
2025
Revenue $6.55B
Op. -$246.2M
RevenueOperating income (or net income)SEC XBRL annual filings, fiscal years mapped to calendar years
Year20212022202320242025
Net income$572.6M$686.5M$321.1M$711.5M-$530.2M
Diluted EPS$0.85$1.01$0.47$1.04$-0.78

Fiscal year ends Dec 31

Tracked investors holding (13F)

Bridgewater AssociatesAdded$3M · 0.0% · held 2 quarters

Weight is the share of each investor's portfolio, as of the quarter end.

Current reports (8-K, last 12 months)

Insider open-market trades (last 12 months)

Source: SEC EDGAR. How figures are combined